4000-520-616
欢迎来到免疫在线!(蚂蚁淘生物旗下平台)  请登录 |  免费注册 |  询价篮
主营:主营:单克隆抗体,重组抗体
咨询热线电话
4000-520-616
当前位置: 首页 > 产品中心 > antigen > Medixbiochemica/Actim®Partus/31900ETAC/1个
商品详细Medixbiochemica/Actim®Partus/31900ETAC/1个
Medixbiochemica/Actim®Partus/31900ETAC/1个
Medixbiochemica/Actim®Partus/31900ETAC/1个
商品编号: 31900ETAC
品牌: medixbiochemica
市场价: ¥0.00
美元价: 0.00
产地: 美国(厂家直采)
公司:
产品分类: 抗原
公司分类: antigen
联系Q Q: 3392242852
电话号码: 4000-520-616
电子邮箱: info@ebiomall.com
商品介绍

Thereliablewaytoidentifyandruleouttheriskofpretermdelivery

Actim®Partusisafastandreliablepoint-of-caretesttoidentifypregnantwomenwitharealriskofpretermorimminentdelivery,evenbeforevisIBLesigns.

Pretermdelivery(birththatoccursbeforethe37thweekofpregnancy)istheleADIngcauseofnewbornmorbidityandmortality.Earlydetectionofhigh-riskpregnanciesischallenging.Halfofpregnantwomenexperienceassociatedsymptoms,yetonly20%oftheseareatrealriskofimmediateorpretermdelivery.

ActimPartusisasimpleandaccuraterapidtesttoidentifyorruleouttheriskofpretermdeliveryfromweek22untilbirth.Thetestcanbeusedforallpregnantwomen,anditisreliableeveninthepresenceofinterferingsubstances.AnegativeActimPartusresultindicatesthatimminentdeliveryishighlyunlikely;low-riskpatientscanthusreturnhome,overtreatmentisavoided,andvaluableresourcesaresaved.

Medixbiochemica/actim-partus-test-kit_test-pouch_components_syv_046.jpg"alt="Actim®Partus">
Keyfacts
  • Reliablyrulesouttheriskofimminentorpretermdeliverywhenfetalmembranesareunbroken
  • Canbeusedfromweek22onwards
  • Easy-to-useone-stepdipsticktest
  • Givestestresultsatthebedsideinjust5minutes,withsamplingcompletedinseconds
  • Testresultsarenotaffectedbyurine,intercourse,semen,vaginalmedications,lubricants,bathingproducts,orinfections
  • Thetestkitcontainsallnecessarymaterialsandcanbestoredatroomtemperature
  • Availableinmultiplepackagesizes

HowActimPartusworks

Actim®Partusidentifiestheriskofpretermdeliverythroughasimplecervicalswabsample.Therapidtestisbasedonhighlyspecificmonoclonalantibodiesthatbindtothephosphorylatedformofinsulin-likegrowthfactorbindingprotein-1(phIGFBP-1).phIGFBP-1isproducedinthedecidua,butleaksintothecervixwhenthedeciduaandchoriondetach.

ApositiveActimPartustestresultindicatesthepresenceoftissuedamage,whichmayleadtopretermdelivery.Anegativetestresult,inturn,meansthattherearenosignificantchangesinthechoriodeciduallayer.Deliveryisthereforeveryunlikelywithinthenext1–2weeks,evenifthepatienthascontractions.ActimPartusisdesignedtogivereliableanswersinminutes,tosupportclinicaldecision-making.

ActimPartushasaveryhigh(98%)negativepredictivevalue(NPV).Therefore,anegativetestresultrulesouttheriskofimminentorpretermdelivery.

BecauseActimPartusisspecifictophIGFBP-1,testscanbecompletedeveninthepresenceofsemen,urine,infections,andmedicalproducts.

ABOUTPHIGFBP-1

  • Producedbydecidua
  • Leaksintothecervixwhendeciduaandchoriondetach
  • phIGFBP-1inacervicalswabisanindicatorfortissuedamage

TABLE1.ClinicalevidenceofActimPartusasapredictorofdeliverywithin7days.

 ReferenceNumberofpatientsGA(wk)Sensitivity%Specificity%PPV%NPV%
Tripathietal.,201646828-3695928697
Azlinetal.,20105124-3680945798
BrikSpinellietal.,201027624-3473662295
Taniretal.,20096824-3793795698
Erogluetal.,20075124-3583844297
Tingetal.,20079424-3469783992
Lembetetal.,20023620-3694858394

HowActimPartushelps

Identifyingpatientswhohaveharmlesscontractionsfromthoseatrealriskofpretermdeliverycanbedifficult.Inpractice,thismeansthatover-diagnosisandover-treatmentarecommon.

ActimPartus®isalreadyinuseallovertheworldandithasbeenincludedin severalnationaltreatmentguidelines.

ActimPartussaveslives,time,andmoney

  • Medicalattentioncanbedirectedtopatientswhoneedit
  • Earlyidentificationofhigh-riskpregnanciesallowstimelytreatment
  • Low-riskpatientswhodonotneedimmediatecarecanbesenthome
  • Unnecessaryuseofmedicationandtheirside-effectscanbeavoided
  • Reducesunrequiredhospitalizationandpatienttransfers
  • Givesexpectingmotherspeaceofmind

HowtouseActimPartus

TheActim®Partustestkitcontainsallnecessarymaterialsandcanbestoredat:

  • Roomtemperature:2–25°C
  • Upto30°Cfor2months
  • Collectacervicalsecretionsampleusingaspeculum

Holdtheswabinfor10-15seconds.

 IfActimPartusiscombinedwithActimPROM,separatesamplesneedtobetakenforthetwotests.ThesampleforActimPartustestmustbetakenfromthecervix,whileavaginalsampleisusedforActimPROMtest.

  • Extractspecimen

PlacetheswabintheSpecimenExtractionSolution,swirlaroundvigorouslyfor10-15seconds,anddiscardtheswab.

  • Activatethetest,step1

Placetheyellowdipareaintotheextractedsampleandholditthereuntilyouseetheliquidfrontentertheresultarea.

 

  • Activatethetest,step2

Removethedipstickfromthesolutionandplaceitinahorizontalposition.

  • Interpretresults

Apositiveresultcanbereadassoonasitbecomesvisible.Twobluelines=riskofpretermorimminentdeliveryishigh.

Anegativeresultshouldbeconfirmedat5minutes.Oneblueline=pretermorimminentdeliveryishighlyunlikely.

ActimPartuscanbeinterpreteddigitallywithActim®1ngeniinstrument

 

HowtoorderActimPartus

Actim®Partustestkitsareavailableinmultiplepackagesizes.Alltestkitscontaininstructionsforuseandindividuallypackedtestpouchesincluding:

  • Dipstick
  • SpecimenExtractionSolutiontube
  • Sterilepolyesterswab
  • Briefinstructionsforuse

Orderinginformation:

  • ActimPartus10testkit,ref.31931ETAC
  • ActimPartus1testkit,ref.31930ETAC
  • ActimPartusSampleCollectionkit,ref.31935ETAC

Including20buffers+20swabs

  • ActimPartusControls,ref:31900ETAC

Actim®PartusControlsareintendedtobeusedwiththeActimPartustestforexternalqualitycontrol.Thecontrolsmayalsobeusedtodemonstratenegativeresultsandweakandstrongpositiveresults.Thecontrolsetincludesnegative,lowpositive,andhighpositivecontrolsaswellasreconstitutionsolution.

ActimPartusbrochures

ActimPartusbrochure,EnglishDownload
ActimPartusbrochure,SpanishDownload
ActimPartusbrochure,ChineseDownload
ActimPartusbrochure,FinnishDownload

ActimPartusinstructionsforuse

ActimPartustestIFUDownload
ActimPartusControlsIFUDownload

Technicaldocuments

DeclarationofConformityActimPartustestDownload
DeclarationofConformityActimPartusControlsDownload
MSDSActimPartustestDownload
MSDSActimPartusControlsDownload
ISO13485:2016certificateDownload
ISO13485:2003CMDCAScertificateDownload

Scientificdocuments

ActimPartuspublicationsDownload
ActimPartusstudysummaryTaniretal.Download
ActimPartusstudysummaryKekkietal.Download
品牌介绍
芬兰Medix Biochemica是*早开始大规模工业生产单克隆抗体的公司之一。单克隆抗体技术发明于1975年,Medix Biochemica于1978年首先将其应用于工业规模生产。因此,Medix Biochemica处于诊断行业单克隆抗体生产商的先进水平。目前已经被30多个国家的150多家公司所应用。所有的生产线完全通过ISO9001:2000认证,Medix Biochemica欢迎客户来参观,可以亲自了解到作为的抗体供应商的Medix Biochemica。灵活、成熟的生产技术能根据客户的专门要求调整生产量,Medix Biochemica具有从几毫克到几百克的抗体生产能力。 Medix Biochemica具有成熟的抗体制备技术,因此,Medix Biochemica也十分熟悉客户制造过程的特殊要求。在不同应用上的深入的信息可以帮助客户理顺研发的项目。Medix Biochemica的科学家和专家可以及时回答客户对于单克隆抗体的任何问题。 对于全球大多数的用户来说高质量和连续的供应链是*重要的,Medix Biochemica拒绝转卖第三方生产商的产品。  Medix Biochemica产品分类包括优生优育(HCGLH PRL FSH)、肿瘤标志物(AFP CEA HB PG PSA NSE)、激素(TSH T3 T4)、心肌类(CK-MB MB CTNI),包括传染病类、血清学等多种标志物蛋白的单抗,各标志物其单抗也有各种不同克隆配对可供用户筛选。